At LLB, we believe in the philosophy that, like education, healthcare is a right, not a privilege. We consciously work on the concept, “Health for All”.

Founded and being lead by accomplished scientists, LLB evolves more scientifically and professionally. A high degree of scientific culture is nurtured with constant generation of innovative spirits among the scientists. Our interests, approaches, key focus and efforts center around unmet and undermet therapeutic areas, emerging diseases and health disorders, and evolving bioscience and technologies to research, develop and bring to market quality and affordable biosimilars, biobetters and biosuperiors besides novel biologics and stem cells.

We have the following biosimilars and reagent molecules in our portfolio under various stages of development and commercial launch: